JamesChristopherShanksMD

PubMed

• 34 citations
  Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).
  Pamela L Kunz, Noah T Graham, Paul J Catalano, Halla S Nimeiri, George A Fisher, Teri A Longacre, Carlos J Suarez, Brock A Martin, James C Yao, Matthew H Kulke, Andrew...> ;Journal of Clinical Oncology. 2023 Mar 1
• 14 citations
  GammaTile® brachytherapy in the treatment of recurrent glioblastomas.
  Dominic J Gessler, Elizabeth C Neil, Rena Shah, Joseph Levine, James Shanks, Christopher Wilke, Margaret Reynolds, Shunqing Zhang, Can Özütemiz, Mehmet Gencturk, Mark ...> ;Neuro-Oncology Advances. 2021 Dec 27
• 1 citations
  A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805]).
  Pili, R., Pili, R., Jegede, O., Jegede, O., Carducci, M. A., Carducci, M. A., Manola, J., Manola, J., Groteluschen, D. L., Groteluschen, D. L., Appleman, L. L., Applem...> ;Clinical genitourinary cancer. 2017 May 27
• 55 citations
  Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research...
  Chandra P. Belani, Suzanne E. Dahlberg, Charles M. Rudin, Martin Fleisher, Helen X. Chen, Naoko Takebe, Mario R. Velasco, William Tester, Keren Sturtz, Christine L. Ha...> ;Cancer. 2016 Aug 1
• 2 citations
  Use of web-based technology in a peer-teaching program.
  James C. Shanks, Robert D. Silver, Ilene B. Harris> ;Academic Medicine. 2000 May 1
• Join now to see all